1
|
Beothe T, Docs J, Kovacs G, Peterfi L. Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours. BMC Nephrol 2024; 25:227. [PMID: 39020292 PMCID: PMC11256699 DOI: 10.1186/s12882-024-03653-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2023] [Accepted: 06/24/2024] [Indexed: 07/19/2024] Open
Abstract
BACKGROUND End-stage and acquired cystic renal disease (ESRD/ACRD) kidneys are characterized by inflammatory remodelling and multiplex renal cell carcinomas (RCC). Eosinophilic vacuolated tumour (EVT) occurs exclusively in ACRD. The aim of this study was to identify the involvement of thioredoxin-interacting protein (TXNIP) and thioredoxin (TXN) in ESRD/ACRD pathology. METHODS Expression of TXNIP and TXN was examined in histological slides of 6 ESRD and 6 ACRD kidneys, precursor lesions and associated tumours as well as of RCCs from the general population by immunohistochemistry. RESULTS Strong TXNIP expression was seen in epithelial cells, myo-fibroblasts and endothelial cells and weak TXN expression in ESRD/ACRD kidneys and tumours. In ACRD specific EVT and its precursors TXN were translocated into nuclei. CONCLUSION The impaired TXNIP/TXN redox homeostasis might be associated with development of multiplex cancer especially of EVT in ESRD/ACRD kidney.
Collapse
Affiliation(s)
- Tamas Beothe
- Department of Urology, Peterfy Sandor Hospital, Budapest, Hungary
| | - Janos Docs
- Department of Urology, Medical School, University of Pecs, Munkacsy Mihaly u. 2, Pecs, 7621, Hungary
| | - Gyula Kovacs
- Department of Urology, Medical School, University of Pecs, Munkacsy Mihaly u. 2, Pecs, 7621, Hungary.
- Medical Faculty, Ruprecht-Karls-University, Heidelberg, Germany.
| | - Lehel Peterfi
- Department of Urology, Medical School, University of Pecs, Munkacsy Mihaly u. 2, Pecs, 7621, Hungary
| |
Collapse
|
2
|
Docs J, Kovacs G, Peterfi L. End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer. J Nephrol 2023:10.1007/s40620-023-01694-w. [PMID: 37439962 PMCID: PMC10393832 DOI: 10.1007/s40620-023-01694-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Accepted: 05/30/2023] [Indexed: 07/14/2023]
Abstract
BACKGROUND End-stage kidney disease and acquired cystic kidney disease are the final stages of chronic kidney disease, leading to loss of kidney function and frequent development of tumours. It has been suggested that an inflammatory microenvironment may be responsible for the progressive kidney remodelling and cancer development. METHODS Our aim was to analyse gene expression suggested to be involved in the remodelling of kidneys in end-stage kidney disease, and in the development of preneoplastic lesions and tumours. Immunohistochemistry was employed to assess the cellular localisation of different genes involved in these pathways on representative tissue sections. RESULTS Cellular (αSMA positive naïve activated fibroblasts, endothelial cells, macrophages) and non-cellular components (cytokines IL6, TGFβ, IL1β, CSF2, fibronectin, laminin, and matrix modifier proteases MMP9 and MMP12) of the inflammatory microenvironment were expressed in the kidneys of patients with end-stage kidney disease. IL6 and FN1 expressing naïve activated fibroblasts and recruited inflammatory cells were the most abundant cellular components of the inflammatory microenvironment. CONCLUSION The progressive inflammatory and fibrotic processes in end-stage kidney disease have features recalling those of a never healing wound and may explain the frequent development of kidney cancer.
Collapse
Affiliation(s)
- Janos Docs
- Department of Urology, Medical School, University of Pecs, 7621, Pecs, Hungary
| | - Gyula Kovacs
- Medical Faculty, Ruprecht-Karls-University, 69120, Heidelberg, Germany.
| | - Lehel Peterfi
- Department of Urology, Medical School, University of Pecs, 7621, Pecs, Hungary
| |
Collapse
|
3
|
Ahmed MM, Shafat Z, Tazyeen S, Ali R, Almashjary MN, Al-Raddadi R, Harakeh S, Alam A, Haque S, Ishrat R. Identification of pathogenic genes associated with CKD: An integrated bioinformatics approach. Front Genet 2022; 13:891055. [PMID: 36035163 PMCID: PMC9403320 DOI: 10.3389/fgene.2022.891055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 06/28/2022] [Indexed: 11/23/2022] Open
Abstract
Chronic kidney disease (CKD) is defined as a persistent abnormality in the structure and function of kidneys and leads to high morbidity and mortality in individuals across the world. Globally, approximately 8%–16% of the population is affected by CKD. Proper screening, staging, diagnosis, and the appropriate management of CKD by primary care clinicians are essential in preventing the adverse outcomes associated with CKD worldwide. In light of this, the identification of biomarkers for the appropriate management of CKD is urgently required. Growing evidence has suggested the role of mRNAs and microRNAs in CKD, however, the gene expression profile of CKD is presently uncertain. The present study aimed to identify diagnostic biomarkers and therapeutic targets for patients with CKD. The human microarray profile datasets, consisting of normal samples and treated samples were analyzed thoroughly to unveil the differentially expressed genes (DEGs). After selection, the interrelationship among DEGs was carried out to identify the overlapping DEGs, which were visualized using the Cytoscape program. Furthermore, the PPI network was constructed from the String database using the selected DEGs. Then, from the PPI network, significant modules and sub-networks were extracted by applying the different centralities methods (closeness, betweenness, stress, etc.) using MCODE, Cytohubba, and Centiserver. After sub-network analysis we identified six overlapped hub genes (RPS5, RPL37A, RPLP0, CXCL8, HLA-A, and ANXA1). Additionally, the enrichment analysis was undertaken on hub genes to determine their significant functions. Furthermore, these six genes were used to find their associated miRNAs and targeted drugs. Finally, two genes CXCL8 and HLA-A were common for Ribavirin drug (the gene-drug interaction), after docking studies HLA-A was selected for further investigation. To conclude our findings, we can say that the identified hub genes and their related miRNAs can serve as potential diagnostic biomarkers and therapeutic targets for CKD treatment strategies.
Collapse
Affiliation(s)
- Mohd Murshad Ahmed
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
| | - Zoya Shafat
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
| | - Safia Tazyeen
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
| | - Rafat Ali
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
- Department of Biosciences, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India
| | - Majed N. Almashjary
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Rajaa Al-Raddadi
- Community Medicine Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Steve Harakeh
- King Fahd Medical Research Center, and Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Aftab Alam
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
| | - Shafiul Haque
- Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia
| | - Romana Ishrat
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
- *Correspondence: Romana Ishrat,
| |
Collapse
|
4
|
Chen R, Xiang F, Hu J, Cao X, Tan X, Jia P, Zhang T, Song N, Fang Y, Ding X, Zou J. Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients. Ren Fail 2017; 39:547-554. [PMID: 28726529 PMCID: PMC6014306 DOI: 10.1080/0886022x.2017.1349672] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Background: CD4 T-cell abnormality, influencing the outcome of the maintained hemodialysis (MHD), is common in patients on dialysis. We try to find out factors associated with the activated CD4 T cells, CD4CD69 T cells, to improve the dialysis quality. Methods: A cross-sectional study was conducted to evaluate the change of CD4CD69 in MHD patients and healthy controls in our hospital from September 2015 to May 2016. A total of 164 MHD patients and 24 healthy controls were included according to the criteria. Univariate and multivariate logistic regression models after correlation analysis were executed to discover the related factors of CD4CD69 T-cell posterior to the division of the CD4CD69 T cell according to its median. Results: The lymphocytes were lower, but the percentage of CD4CD69 T cells was higher in MHD patients compared with healthy controls, even after the propensity score matching based on age and sex. The percentage of CD4 T cells showed no significant difference between the two groups. Further multivariate logistic regression models revealed that CD4CD69 T cell was independently associated with serum total protein (OR 95%CI: 0.830[0.696, 0.990], p = .038), transferrin (OR 95%CI: 3.072[1.131, 8.342], p = .028) and magnesium (OR 95%CI: 16.960[1.030, 279.275], p = .048). Conclusion: The percentage of CD4CD69 T cells, activated CD4 T cells, elevated in hemodialysis patients despite the decrease in lymphocytes. The elevated CD4CD69 T cells were independently associated with serum total protein negatively, but transferrin and magnesium positively. Strengthening nutrition, reducing the concentration of transferrin and magnesium might be beneficial to reduce the activation of CD4 T cells and improve the outcome of MHD patients.
Collapse
Affiliation(s)
- Rongyi Chen
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Fangfang Xiang
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Jiachang Hu
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Xuesen Cao
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Xiao Tan
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Ping Jia
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Ting Zhang
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Nana Song
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Yi Fang
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Xiaoqiang Ding
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| | - Jianzhou Zou
- a Division of Nephrology , Zhongshan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.,b Shanghai Institute of Kidney and Dialysis , Shanghai , China.,c Key Laboratory of Kidney and Blood Purification of Shanghai , Shanghai , China
| |
Collapse
|
5
|
Rahbari-Oskoui F, O'Neill WC. Diagnosis and Management of Acquired Cystic Kidney Disease and Renal Tumors in ESRD Patients. Semin Dial 2017; 30:373-379. [DOI: 10.1111/sdi.12605] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Frederic Rahbari-Oskoui
- Renal Division; Department of Medicine; Emory University School of Medicine; Atlanta Georgia
| | - William Charles O'Neill
- Renal Division; Department of Medicine; Emory University School of Medicine; Atlanta Georgia
| |
Collapse
|
6
|
Berker NK, Bayram A, Tas S, Bakir B, Caliskan Y, Ozcan F, Kilicaslan I, Ozluk Y. Comparison of Renal Anastomosing Hemangiomas in End-Stage and Non–End-Stage Kidneys: A Meta-Analysis With a Report of 2 Cases. Int J Surg Pathol 2017; 25:488-496. [DOI: 10.1177/1066896917706025] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Background. Renal anastomosing hemangioma (RAH) is a very rare distinct entity composed of anastomosing sinusoidal (spleen-like) capillary-sized vessels lined by flat or hobnail endothelial cells. Most of the published cases of RAH occurred in the setting of end-stage renal disease (ESRD). Methods. We present 2 cases of RAH in ESRD along with a literature review. We compared clinicopathologic features of RAHs in end-stage and non–end-stage kidneys. A meta-analysis was conducted with PubMed and a manual search through references of relevant publications. Individual patient data gathered from the literature were used in the analysis. Results. Our systematic review revealed 49 RAHs, including our 2 cases. Thirty-two (65.3%) cases were in ESRD, only 17 (34.7%) were in patients with non-ESRD. RAHs in ESRD were in younger patients, smaller in size, multifocal, and seen more with renal epithelial neoplasms when compared with RAHs in non-ESRD ( P < .05). Extramedullary hematopoiesis was seen mostly in RAHs in ESRD kidneys (85% vs 41.7%) ( P = .018). Follow-up data were available for 25 cases with a mean follow-up of 24.58 ± 38.54 months. Recurrence, metastasis, or death have never been described related to RAH in any patients. Conclusions. In conclusion, RAHs are rare and mostly arise in kidneys with end-stage damage. RAHs in ESRD and non-ESRD differ in terms of clinicopathologic features.
Collapse
Affiliation(s)
| | - Aysel Bayram
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Serap Tas
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Baris Bakir
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Yasar Caliskan
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Faruk Ozcan
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Isin Kilicaslan
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Yasemin Ozluk
- Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| |
Collapse
|
7
|
Deng SM, Yan XC, Liang L, Wang L, Liu Y, Duan JL, Yang ZY, Chang TF, Ruan B, Zheng QJ, Han H. The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice. Biochem Biophys Res Commun 2016; 483:488-494. [PMID: 28007595 DOI: 10.1016/j.bbrc.2016.12.117] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2016] [Accepted: 12/17/2016] [Indexed: 12/11/2022]
Abstract
Although it has been suggested that Dll3, one of the Notch ligands, promotes the proliferation and inhibits the apoptosis of cancer cells, the role of Dll3 in cancers remains unclear. In this study, we found that in the murine Lewis lung carcinoma (LLC) cells, the level of Dll3 mRNA changed upon tumor microenvironment (TME) stimulation, namely, decreased under hypoxia or stimulated with tumor necrosis factor (TNF)-α. Dll3 was also expressed at higher level in human lung carcinoma tissues than in the para-carcinoma tissues. Overexpression of Dll3 in LLC cells promoted cell proliferation and reduced apoptosis in vitro, and enhanced tumor growth when inoculated in vivo in mice. The Dll3-mediated proliferation could be due to increased Akt phosphorylation in LLC cells, because an Akt inhibitor counteracted Dll3-induced proliferation. Moreover, Dll3 overexpression promoted PI3K/Akt signaling through inhibiting Notch signaling.
Collapse
Affiliation(s)
- San-Ming Deng
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China; Department of General Thoracic Surgery, Affiliated Hospital of Logistics University of Chinese People's Armed Police Forces, Tianjin 300162, China
| | - Xian-Chun Yan
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Liang Liang
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Li Wang
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Yuan Liu
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Juan-Li Duan
- Department of Hepatic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Zi-Yan Yang
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Tian-Fang Chang
- Department of Ophthalmology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Bai Ruan
- Department of Hepatic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
| | - Qi-Jun Zheng
- Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
| | - Hua Han
- State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China; Department of Biochemistry and Molecular Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
| |
Collapse
|